AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Clopirest-ASP 150 Capsule IR

Prescription Icon
Prescription Required

Marketer

Matias Healthcare Pvt Ltd

Salt Composition

Aspirin (150mg) + Clopidogrel (75mg)

Overview Clopirest-ASP 150 Capsule IR

CardioGuard 150mg Immediate Release capsules combine two antiplatelet agents to inhibit clot formation within blood vessels. This medication helps prevent strokes and heart attacks in individuals with cardiac conditions and treats acute coronary syndrome (ACS). Consistent daily intake, at the same time each day with food, as directed by your physician, is crucial. Dosage and treatment length vary depending on your condition; complete the prescribed course regardless of feeling improved. A healthy lifestyle, including a low-fat diet, regular exercise, and smoking cessation, enhances its effectiveness. Common side effects are gastrointestinal upset, easy bruising, and epistaxis. Increased bleeding risk necessitates caution with sharp objects. Alcohol consumption is generally discouraged. Inform your doctor of any liver or kidney impairment, pregnancy, breastfeeding plans, or other medications you are currently using, as interactions may occur.

Uses of Clopirest-ASP 150 Capsule IR

Cardiovascular event prevention and acute coronary syndrome management

Common Side effects of Clopirest-ASP 150 Capsule IR:

  • Bruise
  • Gastrointestinal bleeding
  • Increased bleeding tendency
  • Nosebleeds

How Clopirest-ASP 150 Capsule IR works:

Clopidogrel and aspirin, combined in Clopirest-ASP 150 IR capsules, offer dual antiplatelet action to help prevent heart attacks. This medication inhibits platelet aggregation, thereby reducing the risk of dangerous clot formation. It's also indicated for the management of acute coronary syndrome.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Clopirest-ASP 150 Capsule IR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Clopirest-ASP 150mg immediate-release capsules during pregnancy poses a confirmed risk to the fetus. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Clopirest-ASP 150 mg immediate-release capsules while breastfeeding is likely inadvisable. Scant available evidence in humans indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Clopirest-ASP 150mg immediate-release capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Clopirest-ASP 150 mg immediate-release capsules. Dosage modification may be necessary; physician consultation is advised. Clopirest-ASP 150 mg immediate-release capsules are contraindicated in patients with severe kidney disease.

LiverLiverCAUTION

Individuals with liver impairment should use Clopirest-ASP 150 mg immediate-release capsules cautiously, potentially requiring dosage modification. Consult a physician for guidance. Clopirest-ASP 150 mg immediate-release capsules are contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Clopirest-ASP 150 Capsule IR :

Should you forget to take a Clopirest-ASP 150 Capsule IR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Clopirest-ASP 150 Capsule IR

LabelValue
Developing Habits No.
Treatment Category KINSHIP

FAQs on Clopirest-ASP 150 Capsule IR

Clopirest-ASP 150 Capsule IR may be prescribed following a heart attack, coronary artery stent placement, or coronary artery bypass grafting (CABG).
Clopirest-ASP 150 Capsule IR is an antiplatelet medication, preventing blood clots by inhibiting platelet aggregation. This helps reduce the risk of heart attack and stroke in individuals with heart disease, those recovering from a heart attack, or experiencing unstable angina.
Your doctor will determine the appropriate treatment length for Clopirest-ASP 150 Capsule IR, considering your condition, stent type, and any bleeding episodes. While a minimum one-year course is typical, strict adherence to your doctor's prescribed duration is crucial for optimal results. Never stop taking this medication without consulting your doctor; abrupt cessation may significantly increase the risk of stent thrombosis, heart attack, or even death.
Avoid alcohol while taking Clopirest-ASP 150 Capsule IR, as it increases the risk of stomach bleeding. This can manifest as vomiting blood (bright red or dark, coffee-ground-like) or bloody/black, tarry stools. Consult your doctor if you have any concerns.
Clopirest-ASP 150 Capsule IR can cause severe, even life-threatening, bleeding, including easy bruising and prolonged bleeding from minor injuries. Seek immediate medical attention for excessive or prolonged bleeding. Report black, tarry stools or blood in your urine to your doctor. Be alert for stroke symptoms—sudden numbness or weakness (on one or both sides of the body), difficulty walking, confusion, slurred speech, dizziness, or unexplained headache. Contact your doctor immediately if you experience any of these, as stroke, while uncommon, is a potentially fatal side effect of Clopirest-ASP 150 Capsule IR requiring urgent treatment.
Your doctor will determine if you need to discontinue Clopirest-ASP 150 Capsule IR before any surgery or procedure. For planned procedures, they may advise stopping it several days (typically seven) beforehand to reduce bleeding risk. Never stop taking Clopirest-ASP 150 Capsule IR without your doctor's guidance.
Clopirest-ASP 150 Capsule IR is contraindicated in individuals with allergies to it or its components. Avoid use if you have a history of severe liver disease, stomach ulcers, hemorrhagic stroke (including TIA), or a bleeding disorder like hemophilia. Furthermore, this medication should not be taken during pregnancy, attempts to conceive, or while breastfeeding.
Remember to take Clopirest-ASP 150 Capsule IR as directed. If you miss a dose, take it immediately unless it's almost time for your next dose. In that case, skip the missed dose and continue with your regular schedule. Never double a dose.
Minimize activities that could cause bleeding; exercise caution while shaving or brushing your teeth. While ibuprofen and similar painkillers should generally be avoided when taking Clopirest-ASP 150 Capsule IR, consult your doctor if needed for pain relief. This is because painkillers, along with excessive alcohol consumption, can increase the risk of stomach ulcers and bleeding when combined with Clopirest-ASP 150 Capsule IR.
Clopirest-ASP 150 Capsule...
65
MRP 79
17% off